Transactions: Sweden
Filter
Secondary placing of 965,000 shares in Meda AB (SE) — SEK 300 million
Initial public offering of Orexo (SE) — SEK 333 million
Rights issue in Oasmia Pharmaceutical (SE) — SEK 123 million
New share issue in Fastighets AB Klövern (SE) — SEK 260 million
Secondary placing of 19.5 million shares in Fabege (SE) — SEK 663 million
Secondary placing of 7 million shares in Intrum Justitia (SE) — EUR 41 million
Rights issue in Active Biotech (SE) — SEK 255 million
Option program in Biovitrum (SE)
Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion